[ Price : $8.95]
FDA tells Iterum Therapeutics that it needs more time to review company-submitted materials related to the ongoing NDA review for ...[ Price : $8.95]
FDA clears an Activ Surgical 510(k) for the ActivSight Intraoperative Imaging Module for enhanced surgical visualization.[ Price : $8.95]
Georgia, North Carolina, Iowa and Colorado health officials report adverse reactions observed at vaccination sites after administe...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled FDA Recall Regulations 21 CFR Part 7.[ Price : $8.95]
Federal Register notice: CBER makes available version 2.2 of the Specifications for Preparing and Submitting Postmarket Individual...[ Price : $8.95]
Retired FDA psychiatry products director Thomas Laughren joines BetterLife Pharma as a regulatory advisor.[ Price : $8.95]
Bristol Myers Squibb announces positive topline results from the CheckMate-648 Phase 3 Opdivo trial in some esophageal cancers.[ Price : $8.95]
FDA grants Gilead Sciences full approval for Trodelvy (sacituzumab govitecan-hziy) for certain adult patients with unresectable lo...